AtriCure Statistics
Total Valuation
AtriCure has a market cap or net worth of $1.82 billion. The enterprise value is $1.78 billion.
Important Dates
The last earnings date was Tuesday, July 29, 2025, after market close.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AtriCure has 49.70 million shares outstanding. The number of shares has increased by 1.53% in one year.
| Current Share Class | 49.70M |
| Shares Outstanding | 49.70M |
| Shares Change (YoY) | +1.53% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 3.55% |
| Owned by Institutions (%) | 107.73% |
| Float | 47.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.47 |
| Forward PS | 3.21 |
| PB Ratio | 3.93 |
| P/TBV Ratio | 10.28 |
| P/FCF Ratio | 72.13 |
| P/OCF Ratio | 50.07 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 70.53 |
Financial Position
The company has a current ratio of 3.94, with a Debt / Equity ratio of 0.17.
| Current Ratio | 3.94 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | 3.05 |
| Interest Coverage | -5.66 |
Financial Efficiency
Return on equity (ROE) is -7.85% and return on invested capital (ROIC) is -3.95%.
| Return on Equity (ROE) | -7.85% |
| Return on Assets (ROA) | -3.53% |
| Return on Invested Capital (ROIC) | -3.95% |
| Return on Capital Employed (ROCE) | -6.31% |
| Revenue Per Employee | $384,574 |
| Profits Per Employee | -$27,968 |
| Employee Count | 1,300 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 1.69 |
Taxes
In the past 12 months, AtriCure has paid $1.09 million in taxes.
| Income Tax | 1.09M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +73.85% in the last 52 weeks. The beta is 1.62, so AtriCure's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | +73.85% |
| 50-Day Moving Average | 32.83 |
| 200-Day Moving Average | 34.20 |
| Relative Strength Index (RSI) | 63.10 |
| Average Volume (20 Days) | 730,515 |
Short Selling Information
The latest short interest is 2.22 million, so 4.48% of the outstanding shares have been sold short.
| Short Interest | 2.22M |
| Short Previous Month | 1.52M |
| Short % of Shares Out | 4.48% |
| Short % of Float | 4.64% |
| Short Ratio (days to cover) | 3.80 |
Income Statement
In the last 12 months, AtriCure had revenue of $499.95 million and -$36.36 million in losses. Loss per share was -$0.77.
| Revenue | 499.95M |
| Gross Profit | 373.52M |
| Operating Income | -34.07M |
| Pretax Income | -39.27M |
| Net Income | -36.36M |
| EBITDA | -14.07M |
| EBIT | -34.07M |
| Loss Per Share | -$0.77 |
Full Income StatementBalance Sheet
The company has $117.80 million in cash and $77.25 million in debt, giving a net cash position of $40.55 million or $0.82 per share.
| Cash & Cash Equivalents | 117.80M |
| Total Debt | 77.25M |
| Net Cash | 40.55M |
| Net Cash Per Share | $0.82 |
| Equity (Book Value) | 464.49M |
| Book Value Per Share | 9.35 |
| Working Capital | 202.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $36.43 million and capital expenditures -$11.14 million, giving a free cash flow of $25.29 million.
| Operating Cash Flow | 36.43M |
| Capital Expenditures | -11.14M |
| Free Cash Flow | 25.29M |
| FCF Per Share | $0.51 |
Full Cash Flow StatementMargins
Gross margin is 74.71%, with operating and profit margins of -6.82% and -7.27%.
| Gross Margin | 74.71% |
| Operating Margin | -6.82% |
| Pretax Margin | -7.05% |
| Profit Margin | -7.27% |
| EBITDA Margin | -2.81% |
| EBIT Margin | -6.82% |
| FCF Margin | 5.06% |
Dividends & Yields
AtriCure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.53% |
| Shareholder Yield | -1.53% |
| Earnings Yield | -1.99% |
| FCF Yield | 1.39% |
Dividend DetailsAnalyst Forecast
The average price target for AtriCure is $49.60, which is 35.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $49.60 |
| Price Target Difference | 35.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 13.48% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AtriCure has an Altman Z-Score of 6.49 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.49 |
| Piotroski F-Score | 3 |